Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation System for PTSD
This study was terminated in the United States, in Canada, and in Israel. It is testing Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation System for PTSD.
PTSDDeviceFrom 22 Years to 68 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether brain stimulation may be useful for adults experiencing ptsd.
What would participation involve?
Participants may take part in brain stimulation, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Canada, in Israel, and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with ptsd.
What should you check before joining?
Ask about how many sessions are required and who delivers them, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: November 17, 2016
Recruitment status
Terminated
Enrollment listed in the registry
203
Sponsor
Brainsway
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States, Canada, Israel
Age range
From 22 Years to 68 Years
Official registry ID
NCT02479906
Official title
A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Brainsway (HAC-Coil) Deep Transcranial Magnetic Stimulation (DTMS) System for the Treatment of Post-Traumatic Stress Disorder (PTSD)
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT02479906. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Canada · 1 site
Center for Addiction and Mental Health (CAMH)
Toronto, Ontario
Site status: Not listed — confirm with the team
Israel · 2 sites
Be'er Yaacov Mental Health Center
Be’er Ya‘aqov
Site status: Not listed — confirm with the team
Tel Hashomer Hospital
Tel Litwinsky
Site status: Not listed — confirm with the team
United States · 12 sites
CalNeuro Research Group
Los Angeles, California
Site status: Not listed — confirm with the team
Stanford University
Palo Alto, California
Site status: Not listed — confirm with the team
University of California - San Diego Medical Center
San Diego, California
Site status: Not listed — confirm with the team
Kadima Neuropsychiatry
San Diego, California
Site status: Not listed — confirm with the team
University of Florida College of Medicine
Gainesville, Florida
Site status: Not listed — confirm with the team
Advanced Mental Health Care Inc. - Juno Beach
Juno Beach, Florida
Site status: Not listed — confirm with the team
Advanced Mental Health Care Inc.-Palm Beach
Palm Beach, Florida
Site status: Not listed — confirm with the team
Advanced Mental Health Care Inc. - Royal Palm Beach
Royal Palm Beach, Florida
Site status: Not listed — confirm with the team
Yellowbrick Foundation
Evanston, Illinois
Site status: Not listed — confirm with the team
TMS Hope Center of Long Island
New York, New York
Site status: Not listed — confirm with the team
Carolina Partners in Mental Healthcare PLLC
Raleigh, North Carolina
Site status: Not listed — confirm with the team
Medical University Of South Carolina (MUSC)
Charleston, South Carolina
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
Based on the public registry summary, this study is trying to understand: The purpose of the present study is to evaluate the safety and efficacy of Brainsway Deep TMS (DTMS) for the treatment of PTSD. The study team can confirm the exact objective and what it means for you.
Does this study involve a device, app, or technology?
This appears to be a device / app / digital / technology study involving Deep TMS System, Sham Treatment. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Who might this study be for?
This study may concern people with ptsd; age range: From 22 Years to 68 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What should I check about data, monitoring, alerts, and daily use?
If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Brainsway, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
